P-524 Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients: Phase II study

Lung Cancer ◽  
2005 ◽  
Vol 49 ◽  
pp. S255
Author(s):  
S. Lee ◽  
E. Lee ◽  
H. Jeong ◽  
S. Lee ◽  
J. Kim ◽  
...  
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Study ◽  
Line Treatment ◽  
Second Line ◽  
Cell Lung Carcinoma ◽  
Nonsmall Cell Lung Carcinoma

scholarly journals Phase II study of weekly irinotecan plus capecitabine for chemotherapy-naive patients with advanced nonsmall cell lung carcinoma

Cancer ◽  
2005 ◽  
Vol 104 (12) ◽  
pp. 2759-2765 ◽  
Author(s):  
Ji-Youn Han ◽  
Dae Ho Lee ◽  
Sung Young Lee ◽  
Chun Gun Park ◽  
Hyae Young Kim ◽  
...  
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Study ◽  
Cell Lung Carcinoma ◽  
Nonsmall Cell Lung Carcinoma

scholarly journals A phase II study of weekly docetaxel plus capecitabine for patients with advanced nonsmall cell lung carcinoma

Cancer ◽  
2003 ◽  
Vol 98 (9) ◽  
pp. 1918-1924 ◽  
Author(s):  
Ji-Youn Han ◽  
Dae Ho Lee ◽  
Hae Young Kim ◽  
Eun Kyung Hong ◽  
Sung Min Yoon ◽  
...  
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Study ◽  
Cell Lung Carcinoma ◽  
Weekly Docetaxel ◽  
Nonsmall Cell Lung Carcinoma

scholarly journals A Phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma

Cancer ◽  
2000 ◽  
Vol 89 (4) ◽  
pp. 774-782 ◽  
Author(s):  
Christos Kosmas ◽  
Nicolas B. Tsavaris ◽  
Aristidis Polyzos ◽  
Haralambos P. Kalofonos ◽  
Evangelos Sepsas ◽  
...  
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Study ◽  
Cell Lung Carcinoma ◽  
Nonsmall Cell Lung Carcinoma

Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane-refractory/resistant nonsmall cell lung carcinoma

Cancer ◽  
2005 ◽  
Vol 104 (3) ◽  
pp. 561-569 ◽  
Author(s):  
Edward S. Kim ◽  
Merrill S. Kies ◽  
Frank V. Fossella ◽  
Bonnie S. Glisson ◽  
Sara Zaknoen ◽  
...  
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Study ◽  
Farnesyltransferase Inhibitor ◽  
Cell Lung Carcinoma ◽  
Nonsmall Cell Lung Carcinoma

scholarly journals Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients

Cancer ◽  
2000 ◽  
Vol 88 (6) ◽  
pp. 1353-1358 ◽  
Author(s):  
John D. Hainsworth ◽  
Howard A. Burris ◽  
Sharlene Litchy ◽  
Joan B. Erland ◽  
Jeremy K. Hon ◽  
...  
Keyword(s):  
Lung Carcinoma ◽  
Line Treatment ◽  
Second Line ◽  
Cell Lung Carcinoma ◽  
Nonsmall Cell Lung Carcinoma

Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma: A phase II study of the Southwest Oncology Group

Cancer ◽  
1996 ◽  
Vol 78 (5) ◽  
pp. 998-1003 ◽  
Author(s):  
Robert A. Figlin ◽  
John J. Crowley ◽  
Edwin L. Jacobs ◽  
Michael Muirhead ◽  
John Wendall Goodwin ◽  
...  
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Study ◽  
Oncology Group ◽  
Cell Lung Carcinoma ◽  
Southwest Oncology Group ◽  
Nonsmall Cell Lung Carcinoma
Sign in / Sign up

Export Citation Format

Share Document